Sanofi-Aventis Groupe
- A10 - Antidiabéticos
- INSULINA ASPART SANOFI suspension for injection 300 IU/3 ml
- LYXUMIA PEN solution for injection 10 µg/0.2 ml - 20 µg/0.2 ml
- LYXUMIA PREFILLED PEN solution for injection 140 µg/3 ml (10 µg/0.2 ml)
- LYXUMIA PREFILLED PEN solution for injection 280 µg/3 ml (20 µg/0.2 ml)
- LYXUMIA solution for injection 10 µg/0.2 ml
- LYXUMIA solution for injection 20 µg/0.2 ml
- SULIQUA PREFILLED PEN solution for injection 100 IU/ml+33 µg/ml
- SULIQUA PREFILLED PEN solution for injection 100 IU/ml+50 µg/ml
- B01 - Agentes antitrombóticos
- PLAVIX film-coated tablet 300 mg
- PLAVIX film-coated tablet 75 mg
- C01 - Terapia cardíaca
- MULTAQ film-coated tablet 400 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- APROVEL film-coated tablet 150 mg
- APROVEL film-coated tablet 300 mg
- APROVEL film-coated tablet 75 mg
- APROVEL tablet 150 mg
- APROVEL tablet 300 mg
- APROVEL tablet 75 mg
- COAPROVEL film-coated tablet 300 mg+25 mg
- COAPROVEL tablet 150 mg+12.5 mg
- COAPROVEL tablet 300 mg+12.5 mg
- C10 - Agentes modificadores de los lípidos
- PRALUENT PREFILLED PEN solution for injection 75 mg/1 ml
- PRALUENT PREFILLED SYRINGE solution for injection 75 mg/1 ml
- L01 - Antineoplásicos
- JEVTANA concentrate for solution for infusion 60 mg/1.5 ml
- ZALTRAP concentrate for solution for infusion 100 mg/4 ml
- ZALTRAP concentrate for solution for infusion 200 mg/8 ml
- L04 - Inmunosupresores
- AUBAGIO film-coated tablet 14 mg
- AUBAGIO film-coated tablet 7 mg
- V03 - Todos los demás preparados terapéuticos
- FASTURTEC powder and solvent for solution for infusion 1.5 mg+1 ml
- FASTURTEC powder and solvent for solution for infusion 7.5 mg+5 ml